The second edition of “Contemporary Public Health: Principles, Practice, and Policy” features a foreword by University of Kentucky President Eli I. Capilouto and new material centering on the impact of COVID-19 and the opioid epidemic.
LEXINGTON, Ky. (July 29, 2021) The University Press of Kentucky is publishing the second edition of “Contemporary Public Health: Principles, Practice, and Policy” featuring a foreword by University of Kentucky President Eli Capilouto and new material centering on the impact of COVID-19 and the opioid epidemic.
Designed as a supplemental text for introductory courses in public health practice at the undergraduate and graduate levels,
“Contemporary Public Health
University Press of Kentucky Publishes Updated Edition of Contemporary Public Health, Featuring COVID-19 and Opioid Epidemic Additions
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.
London Man Arrested After Double Shooting
sam1039.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sam1039.com Daily Mail and Mail on Sunday newspapers.
Lebanon resident concerned about sidewalk issues | LebanonEnterprise com
lebanonenterprise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lebanonenterprise.com Daily Mail and Mail on Sunday newspapers.
FDA panel does not recommend approval of roxadustat for anemia
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Subscribe
ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
After more than 7 hours of discussion, the Cardiovascular and Renal Drugs Advisory Committee of the FDA voted against approval of roxadustat for the treatment of anemia due to chronic kidney disease for patients not on dialysis and on dialysis.